Biological Material Analysis TRIZ Cases

Paired antibodies targeting distinct epitopes on the SARS-CoV-2 nucleocapsid protein enhance detection specificity and lower the limit of detection.

VHH domain antibodies bind the IL-2 receptor complex to selectively stimulate regulatory T cells, resolving specificity and half-life trade-offs.

Distinct epitope antibodies quantify shed FOLR1 in patient samples, eliminating competitive inhibition from concurrent huMov19 therapy.

Anti-GAG motif antibodies bind specific cell surface glycans to identify and isolate distinct cellular phenotypes.

Conjugating the galactose-alpha-1,3-galactose epitope to a macromolecule carrier isolates specific IgE levels from general immune responses.

Dual control thresholds compare signals at distinct times to extend dynamic range and reduce hook effect errors.

Rv2626c-derived peptide composition differentiates latent from active tuberculosis by measuring interferon-gamma levels in peripheral blood mononuclear cells.

Distributed microfluidic channels shift bioreagent transport from diffusion to advection, reducing immunohistochemistry processing time from hours to minutes.

Fluorescent labeling of intracellular receptors enables automated optical detection through flow cytometry for rapid cell analysis.

Monoclonal antibody 2E7 detects muramyl peptides via picomolar affinity, overcoming low specificity limits of existing antibodies.

Antibodies 22C3 and 20C3 detect human PD-L1 expression in FFPE tissue, resolving low specificity of prior antibodies.

FLNA binding antibodies detect filamin A to distinguish aggressive from non-aggressive prostate cancer, improving diagnostic accuracy beyond PSA limitations.

Chemically modified antibiotics target mitochondria to inhibit biogenesis, eradicating resistant cancer stem cells that survive conventional therapies.

Grafted CDR sequences in humanized anti-CD47 antibodies block CD47-SIRPα interactions to promote tumor cell phagocytosis without erythrocyte agglutination.

Segmented immunoassay detects Mx-B and CRP markers simultaneously, reducing antibiotic misuse.

Secondary moiety co-deposition enables kinetic differential drift correction for frequency-insensitive aptamer sensors in whole blood.

Composite affinity column with monoclonal antibodies purifies five mycotoxins, eliminating solvent interference for accurate LC-MS quantification.

ENOX2 transcript variants catalyze ionic silver or gold reduction to colloidal nanoparticles for semi-quantitative light scattering analysis.

Intersecting sample and reagent sorbent strips manage high saliva viscosity by preventing aggregation and flooding, enhancing assay sensitivity.

Segmented antibody design isolates TGF-β3 binding to block cancer progression while preserving inflammatory homeostasis.

Culturing pluripotent stem cell-derived hepatocytes with cyclic adenosine monophosphate and Janus kinase inhibitors drives cellular maturation.

Segmentation and extraction isolate 3,000 Da immune modulators to balance T cell activity while reducing manufacturing complexity.

Protruding collecting member gathers tear samples directly from the eye surface, reducing pain and improving sensitivity.

Chemical modification of Globo H glycans resolves the trade-off between synthesis complexity and immunogenicity to induce robust IgG responses.

Denaturation and blocking steps eliminate secondary antibody cross-reactivity when using same-species primary antibodies for CD3 and CD16 detection.

Automated microscopy identifies circulating melanoma cells using multi-biomarker agents and morphological assessment.

Anti-KAAG1 antibodies bind KAAG1-expressing ovarian cancer cells, resolving the contradiction between treatment efficacy and severe side effects.

Cationic polymer in alkaline buffer boosts charge difference, cutting separation time from ten minutes to under two hundred seconds.

A lateral flow immunoassay detects beta-trace protein in nasal samples using capillary action and specific test lines.

Anti-idiotype antibodies resolve rapid CD22 internalization to enable accurate pharmacokinetic evaluation.

Segmenting Procalcitonin epitopes across residues 2-52 and 53-116 resolves detection inaccuracies caused by molecular fragmentation in bodily fluids.

Streptavidin-biotin immobilization anchors chemically probed proteins to a chip, enabling sequencing at lower concentrations than conventional methods.

Disposable test strips with pre-coated antibodies enable rapid, high-throughput mycophenolic acid testing without expensive equipment or cold chain storage.

Quaternary amine lysis extracts extracellular matrix molecules for direct immunological quantification and visualization.

An enzyme-linked immunosorbent assay detects giant panda relaxin-3 using a specific monoclonal antibody and polyclonal labeling antibody.

Incorporating reductive saccharides like glucose in the detection region prevents blank color development while maintaining analyte detection sensitivity.

A microfluidic device mimics the myocardial microenvironment using a synthetic vascular network to control oxygen perfusion.

Anti-Ezrin monoclonal antibodies detect Ezrin protein in feces to overcome low sensitivity of existing colorectal cancer tumor markers.

E. coli expression of recombinant Wisteria floribunda lectin resolves lot variability and enables mass production of specific GalNAc binders.

A multianalyte assay system uses saponin buffers and segmented probes to detect multiple targets simultaneously.

Humanized 1E9 antibody inhibits CD73 catalytic activity, relieving AMP-dependent suppression of T cell proliferation and IFN-gamma secretion.

Novel anti-IL-4RA antibodies bind interleukin-4 receptor alpha to block cytokine signaling.

Labelled anti-C1q reagents bind complement factor C1q complexes to resolve sensitivity and specificity trade-offs in antibody detection.

Merged ring resonators on a single chip compensate for thermal drift and fabrication variance, maintaining spectral accuracy below 5 picometers.

Detecting GPR30 protein levels distinguishes high-risk patients from standard estrogen receptor-positive groups, enabling tailored adjuvant therapy.

A method calculates biochemical marker ratios and products to assess physiological balance and dynamics.

A light shield exerts pressure across a test strip width to constrain fluid flow within an electronic diagnostic device.

Combining receptors with chelating agents and C2-C6 polyols creates stable liquid solutions for diagnostic assays.

Molecular dynamics simulations estimate binding energy to the GPR81 receptor for ligand screening.